Pinostrobin pentanoate as a selective estrogen receptor-α antagonist in breast cancer: integrated in silico and in vitro evaluation
- DOI
- 10.4103/rps.rps_108_25
- Published
- 2026-07
- Container
- Research in Pharmaceutical Sciences
- Publisher
- Ovid Technologies (Wolters Kluwer Health)
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.4103/rps.rps_108_25,
title = {Pinostrobin pentanoate as a selective estrogen receptor-α antagonist in breast cancer: integrated in silico and in vitro evaluation},
author = {Tri Widiandani and Delis Susilawati and Ave Rahman and Siti Rahmah and Melanny Ika Sulistyowaty and A. Mu’thi Andy Suryadi and Bambang Tri Purwanto and Siswandono Siswodihardjo},
year = {2026},
journal = {Research in Pharmaceutical Sciences},
doi = {10.4103/rps.rps_108_25},
url = {https://doi.org/10.4103/rps.rps_108_25}
}RIS
TY - JOUR TI - Pinostrobin pentanoate as a selective estrogen receptor-α antagonist in breast cancer: integrated in silico and in vitro evaluation AU - Tri Widiandani AU - Delis Susilawati AU - Ave Rahman AU - Siti Rahmah AU - Melanny Ika Sulistyowaty AU - A. Mu’thi Andy Suryadi AU - Bambang Tri Purwanto AU - Siswandono Siswodihardjo PY - 2026 JO - Research in Pharmaceutical Sciences DO - 10.4103/rps.rps_108_25 UR - https://doi.org/10.4103/rps.rps_108_25 ER -
APA
Widiandani, T., Susilawati, D., Rahman, A., Rahmah, S., Sulistyowaty, M. I., Suryadi, A. M. A., Purwanto, B. T., & Siswodihardjo, S. (2026). Pinostrobin pentanoate as a selective estrogen receptor-α antagonist in breast cancer: integrated in silico and in vitro evaluation. Research in Pharmaceutical Sciences. https://doi.org/10.4103/rps.rps_108_25
Source records
- crossref · retrieved 2026-09-25T04:15:20.851Z